Kathy Boyd David
For the latest episode of the JNC CardioConnect podcast, Marcelo F. Di Carli, MD, MASNC, brought together 4 experts for a conversation about where the field of cardiac amyloidosis stands…
On May 21, the House Ways and Means Committee passed H.R. 8163, the Provider Reimbursement Stability Act. This legislation would increase the budget-neutrality threshold from $20 million to $54.3 million…
ICNC2026 hosted the first Avijit Lahiri Young Investigator Awards Competition, where 6 early-career investigators presented their research and took questions from the judges. The event honors the late Avijit Lahiri,…
“[Cardiac PET] gives us very good data, probably the most accurate, about whether a patient has an obstructive blockage or not … [PET] is also the only noninvasive test available…
The Journal of Nuclear Cardiology has just released a new JNC Compendium that provides a clear, up-to-date summary of what is known about cardiac amyloidosis as well as insights on…
The Phase III REVEAL study met its primary endpoints demonstrating sensitivity and specificity of the PET/CT investigational radiotracer I-124 evuzamitide for diagnosing cardiac amyloidosis based on visual scan interpretation, according…
Episode 13 of JNC CardioConnect highlights the results of the landmark AURORA sub-study, which found F-18 flurpiridaz PET significantly outperformed traditional SPECT imaging in detecting obstructive coronary artery disease in…